title: [The effect of exogenous antioxidants on the antioxidant status of erythrocytes and hepcidin content in blood of patients with disorders of iron metabolism regulation].
abstract: In many diseases associated with impairments in iron metabolism, erythrocytes exhibit an increased sensitivity to oxidative stress induced in vitro. In this study, we have examined the antioxidant status of erythrocytes from healthy donors and from 12 patients with disorders of iron homeostasis by measuring the extent of t-BHP-induced hemolysis in vitro. The extent of hemolysis observed with patient erythrocytes was significantly higher than that observed in experiment with normal cells. After therapeutic infusions of the antioxidants mexidol or emoxypin, oxidative hemolysis in patients was restored to normal values and blood hepcidin content increased significantly. A significant correlation was observed between hepcidin concentration after treatment and t-BHP-induced hemolysis before treatment. These data suggest that antioxidants may exert a favorable effect under pathological conditions associated with iron overload disease.
authors: S P
authors: SP
authors: Shcherbinina
authors: A A
authors: AA
authors: Levina
authors: I L
authors: IL
authors: Lisovskaia
authors: F I
authors: FI
authors: Ataullakhanov
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D064451:Hepcidins / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000097:blood; D019189:Iron Metabolism Disorders / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010847:Picolines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D064451:Hepcidins; D010847:Picolines; C070020:emoxypine succinate; D007501:Iron; C009820:6-methyl-2-ethyl-3-hydroxypyridine